Daniel C.
- Country
- Portugal
- Department
- Serviço de Endocrinologia
Research Overview
- Phase 3 Randomized Study Comparing Asundexian and Apixaban for Stroke Prevention in Atrial Fibrillation Patients at Risk
- A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active-Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation
- A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Impactof Maridebart Cafraglutide on Cardiovascular Outcomes in Participants with Atherosclerotic Cardiovascular Disease and Overweight or Obesity (MARITIME-CV)
Data & Insights
Has run more than one trial at 368 of 1084 partner sites.
Specializations
Cardiovascular Medicine
The investigator specializes in treating atrial fibrillation and its complications, with particular focus on stroke prevention in cardiac patients. Their work extends to evaluating novel therapeutic approaches for managing cardiac arrhythmias.
- Cardiac Rhythm Management
- Stroke Prevention Strategies
- Cardioembolic Events
Their expertise includes assessment of anticoagulation therapies for cardiac conditions.
Metabolic Disorders
The investigator focuses on treating hypertriglyceridemia and its relationship with cardiovascular health. Their work encompasses managing lipid disorders in patients with concurrent cardiovascular conditions.
- Lipid Management
- Triglyceride Reduction
- Metabolic Risk Factors
Their research interests include innovative treatments for complex lipid disorders.
Vascular Medicine
The investigator concentrates on atherosclerotic cardiovascular disease management and prevention of systemic embolism. Their expertise includes comprehensive vascular risk assessment and treatment.
- Atherosclerosis Treatment
- Vascular Risk Management
- Thrombosis Prevention
Their work involves evaluation of advanced therapeutic options for vascular conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.